192 related articles for article (PubMed ID: 26471305)
1. Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key β-cell factors under diabetic conditions.
Shimo N; Matsuoka TA; Miyatsuka T; Takebe S; Tochino Y; Takahara M; Kaneto H; Shimomura I
Biochem Biophys Res Commun; 2015 Nov; 467(4):948-54. PubMed ID: 26471305
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.
Cheng ST; Chen L; Li SY; Mayoux E; Leung PS
PLoS One; 2016; 11(1):e0147391. PubMed ID: 26807719
[TBL] [Abstract][Full Text] [Related]
3. Early Treatment with Empagliflozin and GABA Improves
Daems C; Welsch S; Boughaleb H; Vanderroost J; Robert A; Sokal E; Lysy PA
J Diabetes Res; 2019; 2019():2813489. PubMed ID: 31467926
[TBL] [Abstract][Full Text] [Related]
4. The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.
Oelze M; Kröller-Schön S; Welschof P; Jansen T; Hausding M; Mikhed Y; Stamm P; Mader M; Zinßius E; Agdauletova S; Gottschlich A; Steven S; Schulz E; Bottari SP; Mayoux E; Münzel T; Daiber A
PLoS One; 2014; 9(11):e112394. PubMed ID: 25402275
[TBL] [Abstract][Full Text] [Related]
5. SGLT2-i improves markers of islet endothelial cell function in db/db diabetic mice.
Hogan MF; Hackney DJ; Aplin AC; Mundinger TO; Larmore MJ; Castillo JJ; Esser N; Zraika S; Hull RL
J Endocrinol; 2021 Feb; 248(2):95-106. PubMed ID: 33337344
[TBL] [Abstract][Full Text] [Related]
6. The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin.
Kern M; Klöting N; Mark M; Mayoux E; Klein T; Blüher M
Metabolism; 2016 Feb; 65(2):114-23. PubMed ID: 26773934
[TBL] [Abstract][Full Text] [Related]
7. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
Ghanaat-Pour H; Sjöholm A
Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
[TBL] [Abstract][Full Text] [Related]
9. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
Gembardt F; Bartaun C; Jarzebska N; Mayoux E; Todorov VT; Hohenstein B; Hugo C
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F317-25. PubMed ID: 24944269
[TBL] [Abstract][Full Text] [Related]
10. [Improvement of the function of islet beta and alpha cells by intervention against glucotoxicity: experiment with rats].
He QH; Zhou YS; Wang Z; Wang S; Mou ZQ; Li J; Chi JM
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):374-7. PubMed ID: 18581888
[TBL] [Abstract][Full Text] [Related]
11. Preserving Mafa expression in diabetic islet β-cells improves glycemic control in vivo.
Matsuoka TA; Kaneto H; Kawashima S; Miyatsuka T; Tochino Y; Yoshikawa A; Imagawa A; Miyazaki J; Gannon M; Stein R; Shimomura I
J Biol Chem; 2015 Mar; 290(12):7647-57. PubMed ID: 25645923
[TBL] [Abstract][Full Text] [Related]
12. Testosterone reduces AGTR1 expression to prevent β-cell and islet apoptosis from glucotoxicity.
Kooptiwut S; Hanchang W; Semprasert N; Junking M; Limjindaporn T; Yenchitsomanus PT
J Endocrinol; 2015 Mar; 224(3):215-24. PubMed ID: 25512346
[TBL] [Abstract][Full Text] [Related]
13. Glucotoxicity and pancreatic proteomics.
Brunner Y; Schvartz D; Priego-Capote F; Couté Y; Sanchez JC
J Proteomics; 2009 Jan; 71(6):576-91. PubMed ID: 19027091
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment.
Macha S; Mattheus M; Halabi A; Pinnetti S; Woerle HJ; Broedl UC
Diabetes Obes Metab; 2014 Mar; 16(3):215-22. PubMed ID: 23859488
[TBL] [Abstract][Full Text] [Related]
15. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity.
Wang H; Kouri G; Wollheim CB
J Cell Sci; 2005 Sep; 118(Pt 17):3905-15. PubMed ID: 16091421
[TBL] [Abstract][Full Text] [Related]
16. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
17. Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity.
Poitout V; Robertson RP
Endocrinology; 2002 Feb; 143(2):339-42. PubMed ID: 11796484
[TBL] [Abstract][Full Text] [Related]
18. Involvement of dying beta cell originated messenger molecules in differentiation of pancreatic mesenchymal stem cells under glucotoxic and glucolipotoxic conditions.
Gezginci-Oktayoglu S; Onay-Ucar E; Sancar-Bas S; Karatug-Kacar A; Arda ESN; Bolkent S
J Cell Physiol; 2018 May; 233(5):4235-4244. PubMed ID: 29058819
[TBL] [Abstract][Full Text] [Related]
19. Isosteviol increases insulin sensitivity and changes gene expression of key insulin regulatory genes and transcription factors in islets of the diabetic KKAy mouse.
Nordentoft I; Jeppesen PB; Hong J; Abudula R; Hermansen K
Diabetes Obes Metab; 2008 Sep; 10(10):939-49. PubMed ID: 18201205
[TBL] [Abstract][Full Text] [Related]
20. Glucose-induced insulin mRNA accumulation is impaired in islets from neonatal streptozotocin-treated rats.
Briaud I; Rouault C; Bailbé D; Portha B; Reach G; Poitout V
Horm Metab Res; 2000 Feb; 32(2):53-6. PubMed ID: 10741685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
